Literature DB >> 12515876

The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.

Andrzej Szuba1, William S Shin, H William Strauss, Stanley Rockson.   

Abstract

Lymphedema-edema that results from chronic lymphatic insufficiency-is a chronic debilitating disease that is frequently misdiagnosed, treated too late, or not treated at all. There are, however, effective therapies for lymphedema that can be implemented, particularly after the disorder is properly diagnosed and characterized with lymphoscintigraphy. On the basis of the lymphoscintigraphic image pattern, it is often possible to determine whether the limb swelling is due to lymphedema and, if so, whether compression garments, massage, or surgery is indicated. Effective use of lymphoscintigraphy to plan therapy requires an understanding of the pathophysiology of lymphedema and the influence of technical factors such as selection of the radiopharmaceutical, imaging times after injection, and patient activity after injection on the images. In addition to reviewing the anatomy and physiology of the lymphatic system, we review physiologic principles of lymphatic imaging with lymphoscintigraphy, discuss different qualitative and quantitative lymphoscintigraphic techniques and their clinical applications, and present clinical cases depicting typical lymphoscintigraphic findings.

Entities:  

Mesh:

Year:  2003        PMID: 12515876

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  77 in total

1.  Lymphoscintigraphy In a Case of Recurrent Chylopericardium.

Authors:  Lokeshwaran Madurai Kalimuthu; Vivek Kumar Saini; Prasanta Kumar Pradhan
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

2.  Biofluid mechanics of special organs and the issue of system control. Sixth International Bio-Fluid Mechanics Symposium and Workshop, March 28-30, 2008 Pasadena, California.

Authors:  Mair Zamir; James E Moore; Hideki Fujioka; Donald P Gaver
Journal:  Ann Biomed Eng       Date:  2010-03       Impact factor: 3.934

3.  Lymphedema.

Authors:  Stanley G Rockson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

4.  SPECT-CT: a valuable method to document the regeneration of lymphatics and autotransplanted lymph node fragments.

Authors:  K S Blum; C Radtke; W H Knapp; R Pabst; K F Gratz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-11       Impact factor: 9.236

5.  Thighplasty after bariatric surgery: evaluation of lymphatic drainage in lower extremities.

Authors:  Cristina Hachul Moreno; Henrique Jorge Guedes Neto; Américo Helene Junior; Carlos Alberto Malheiros
Journal:  Obes Surg       Date:  2008-06-11       Impact factor: 4.129

6.  Label-free optical lymphangiography: development of an automatic segmentation method applied to optical coherence tomography to visualize lymphatic vessels using Hessian filters.

Authors:  Siavash Yousefi; Jia Qin; Zhongwei Zhi; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2013-08       Impact factor: 3.170

7.  Label-free optical imaging of lymphatic vessels within tissue beds in vivo.

Authors:  Siavash Yousefi; Zhongwei Zhi; Ruikang K Wang
Journal:  IEEE J Sel Top Quantum Electron       Date:  2014 Mar-Apr       Impact factor: 4.544

Review 8.  New horizons for imaging lymphatic function.

Authors:  Ruchi Sharma; Juliet A Wendt; John C Rasmussen; Kristen E Adams; Milton V Marshall; Eva M Sevick-Muraca
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.

Authors:  Cynthia A Davies-Venn; Bonnie Angermiller; Nathaniel Wilganowski; Pradip Ghosh; Barrett R Harvey; Grace Wu; Sunkuk Kwon; Melissa B Aldrich; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

10.  Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors.

Authors:  Nandita Das; Richard N Baumgartner; Elizabeth C Riley; Christina M Pinkston; Dongyan Yang; Kathy B Baumgartner
Journal:  J Cancer Surviv       Date:  2015-04-26       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.